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The oncoprotein induced transcript 3 (OIT3), also named liver-speciﬁc zona pellucida domain-
containing protein (LZP), has been shown to be expressed in kidney, and was conﬁrmed to interact
with the Tamm–Horsfall glycoprotein (THP). However, the function of OIT3 in kidney remains
unclear. In this study we found that serum uric acid level of Oit3 null mice was signiﬁcantly lower
than that in wild type controls, whereas the excretion of uric acid in urine increased in the mutant
mouse. Signiﬁcantly, the excretion of THP in urine also increased while renal THP decreased in Oit3
null mice. Our data suggest that OIT3 could maintain urate homeostasis by regulating the excretion
and reabsorption of uric acid in renal tubule via cooperating with THP.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian proteins with zona pellucida (ZP) domain are des-
ignated as ZP domain-containing proteins. These proteins are char-
acterized by an extracellular motif of 260 amino acid residues, the
ZP domain, which is thought to act as a polymerization module,
promoting the formation of homo- or heterotypic ﬁlaments [1].
The ﬁrst ZP protein, ZP1 was cloned from oocytes and shown to
be involved in the acrosome reaction [2]. Since then, more and
more ZP domain-containing proteins have been cloned frommulti-
ple tissues or cells. Recently, we identiﬁed the human and mouse
liver-speciﬁc zona pellucida domain-containing protein (LZP), also
named oncoprotein induced transcript 3 (OIT3), which functions as
a secreted protein [3,4]. In our extending study, this gene was
found to be expressed in mouse and rat kidney, where OIT3 was
co-localized with Tamm–Horsfall protein (THP) in the renal thick
ascending limb of Henle’s loop (TAL). The in vivo interaction be-
tween OIT3 and THP was further conﬁrmed in kidney and urine
by co-immunoprecipitation assay, and the in vitro interaction
was detected by GST pull-down assay [5].
THP, also called uromodulin, contains a complex glycosyl
moiety with variable structure and is expressed in distal convoluted
tubule and the thick ascending limb of renal tubules, as well aschemical Societies. Published by E
Laboratory for Disease and
Center at Shanghai, 351 Guo
50800402.excreted in urine [6]. THP null mice showed inability to concentrate
urine and a tendency for calcium oxalate stone formation, which
suggested its role during normal renal physiology [7,8]. Moreover,
the ability to clear urinary tract bacteria was also impaired in the
THP null mice [9]. Given the interaction between OIT3 and THP pro-
teins in kidney, we suspected OIT3might be involved in normal kid-
ney physiology and also wanted to know whether the putative
function of OIT3 in kidney works through a THP interaction.
2. Materials and methods
2.1. Generation of Oit3 null mice
The Oit3 null mice were generated by collaborating with the
Shanghai Research Center for Model Organisms. The mouse Oit3
gene was isolated from BAC clones (Geneservice, bMQ-207B8). A
replacement targeting vector pBR322-MC1-hsvTK was constructed
incorporating a 7.2 kb 50 arm and 3.4 kb 30 arm ﬂanking a neomycin
resistance cassette replacing the ﬁrst two exons of the Oit3 gene
(Fig. 1A). The linearized vector was electroporated into embryonic
stem cells (PluriStem 129/S6 Murine ES cells, Chemicon, Billerica,
MA, USA), obtained from mouse strain 129/S6/SvEv. Successfully
transfected embryonic stem cells were injected into developing
blastocysts from C57Bl/6 J mice to obtain chimeric mice. Chimeric
mice were bred with C57Bl/6 J female mice and screened by
polymerase chain reaction (PCR) of tail DNA to obtain mice hetero-
zygous for OIT3 deﬁciency. All animal experiments described
herein were approved by the Shanghai Institutional Animal Care
and Use Committees (protocol numbers 2010-0006). Mice werelsevier B.V. All rights reserved.
Fig. 1. Establishment of the Oit3 null mouse model. (A) Strategy for disrupting the mouse Oit3 gene. The Oit3 targeting construct was 13.9 kb, consisting of a 7.2 kb 50-arm, a
3.4 kb 30-arm, and a 3.3 kb neomycin resistance cassette (Neo) replacing exons 1 and 2. The targeting vector also contained a further 6.2 kb including the Herpes Simplex virus
thymidine kinase gene (TK). (B) The DNA from tail biopsies was ampliﬁed by PCR for identiﬁcation. Oit3 null mice have a product of 642 bp, while wild type mice have a band
corresponding to 333 bp. Heterozygous mice have both bands. (C and D) mRNA and protein expression of OIT3 in liver and kidney were analyzed by RT-PCR and Western
blotting assays, respectively. (E) Immunohistochemical staining on kidney from wild type and Oit3 null mice. OIT3 locates within renal tubules in WT mice, as indicated by
arrows.
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access to food and water. The heterozygous mice were bred with
each other to obtain Oit3+/+ and Oit3/ offspring. The absence of
OIT3 was conﬁrmed by PCR, Western blot, and by immunohisto-
chemistry. The Oit3 null mice revealed no gross anomalies. They
grew and bred normally.
2.2. Extraction of DNA, RNA and RT-PCR
The mouse DNA for PCR genotyping was from the tail and ex-
tracted with Qiagen DNA Extraction Kit. Total RNA was extracted
with TRizol reagent (Invitrogen) based on manufacturer’s protocol.
RT reactions were carried out at 37 C for 1 h in 20 ll reaction mix-
tures containing 1 lg total RNA, 10 pmol randomprimers, 200 units
SuperScript II RT (Promega). The primers used in PCR were as fol-
lowed: WT allele Forward: AAGGCTCCGTTACAGGCAGTT and Re-
verse: CA GCTGCCAGGAGTGGATAG or the neomycin resistance
gene Forward CTGAGCCCAGAAAGCGAAGGA and Reverse: CACCCA
TTGGTCA CTACAC. The primers for OIT3 mRNA identiﬁcation For-
ward: CTGAAGATAATCACACTTGCCAAGTC and Reverse: CGATGTT
GCTGGCCA CGATTTT. The PCR products were separated by
electrophoresis on a 2% agarose gel. Samples were also analyzedwith SYBR green-based qPCR performed on a TAKARA Sequence
Detection System. The primers used in qPCR were as followed:
THP Forward: TCAGCCTGAAGACCTCCC TA, Reverse: GAAAAGCCT-
CAGTGGACAGC; Xanthine Oxidase Forward: CCACCCTGCTCTTTCA-
GAAG, Reverse: TTCTCATAGCGGGG AATGTC; Urate Oxidase
Forward: GGCCCTATGACAAAGGTGAA, Reverse: GCAGCAAAACCTCTT-
CCTTG. All values were normalized to b-actin levels as previously
described [10]. The mRNA level of gene expression was calculated
as 2DDCT.
2.3. Western blotting (WB) assay
Protein samples were separated by 8% SDS-PAGE, and then
transferred to Hybond-C extra nitrocellulose membrane (Amersham
Pharmacia Biotech). After being blocked in PBS containing 5% non-
fat milk powder and 0.5% Tween-20, the membrane was incubated
with rabbit anti-OIT3 antibody [3], mouse anti-THP antibody
(Santa Cruz), rabbit anti-URAT1 (Abnova) and mouse anti-b-actin
(Santa Cruz) at room temperature for 2 h, followed after washing
by incubation with IRDyeTM800-labeled secondary antibodies
(Li-Cor Biosciences Inc., Lincoln, Nebraska) for 1 h at room temper-
ature. The signals were detected by Odyssey infrared imaging
762 B. Yan et al. / FEBS Letters 586 (2012) 760–765system (Li-Cor Biosciences Inc.). The quantitative ratios are shown
as relative optical densities of bands normalized to the expression
of b-actin (kidney). The density of urine THP is estimated based on




ing 0.3% H2O2 to quench endogenous peroxidase activity. After
incubating in 0.01 M Sodium Citrate Solution buffer (pH 6.0) at
85 C for 15 min, the sections were blocked with 20% goat serum
in PBS at 37 C for 1 h. Then the sections were incubated with anti-
OIT3 polyclonal antibodies at 4 C overnight, followed by incubation
with the horseradish peroxidase (HRP)-conjugated anti-rabbit anti-
bodies (DACO, Kyoto, Japan) at 37 C for 1 h. The signals were
detected with Diaminobenzidine (DAB) Substrate Kit (Vector
Laboratories, Inc., Burlingame, CA) according to manufacturer’s
instructions.
2.5. Analyses of serum and urine
The mice were used at age 6–8 weeks. The animals received
standard mouse chow and were allowed drinking water ad libitum.
Each group had 6–8 mice and mice were placed individually into
metabolism cages. Urine volume, osmolality (freezing point
depression), sodium, chloride, potassium, creatinine, uric acid,
and total protein were determined by routine automated methods.
The urine samples were checked for the presence of THP by
Western Blot. Thereafter, animals were killed after anesthesia with
4% chloral hydrate intraperitoneal injection (0.01 ml/g). Blood was
taken from mouse orbit and centrifuged at 1000g at room tem-
perature. Serum was collected and stored in 80 C. The sera were
analyzed with an autobiochemistry instrument (Hitachi 7600,
Japan).
2.6. Statistical analysis
Data are shown as means ± S.D. and were analyzed by using an
ANOVA test and Mann–Whitney U test.3. Results
3.1. Establishment of an Oit3 null mouse model
We generated Oit3 null mice by targeting the ﬁrst two exons of
the Oit3 gene via homologous DNA recombination in embryonicTable 1
Serum indices related to liver and kidney functions in wild type and OIT3 null mice.
Items Male
Wild type Homoz
Albumin (g/l) 33 ± 1.67 29.67 ±
Globulin (g/l) 20 ± 3.09 21 ±
AST (u) 91.83 ± 21.57 98.7 ±
ALT (u) 43.68 ± 20.72 40.2 ±
Cholesterol (mmol/l) 3.45 ± 0.84 3.34 ±
Na+ (mmol/l) 147.25 ± 2.68 146.8 ±
K+ (mmol/l) 4.76 ± 0.17 4.69 ±
Cl (mmol/l) 108.25 ± 2.04 104.8 ±
Uric acid (lmol/l) 127.58 ± 52.04 96.86 ±
Creatinine (lmol/l) 15.64 ± 5.17 14.9 ±
BUN (lmol/l) 10.14 ± 2.8 10.33 ±
Values are means ± S.D.; n = 8–10/genotype and gender. Statistical analysis was performe
mice, respectively. AST, aspartate amino-transferase; ALT, alanine amino-transferase; BUstem (ES) cells (Fig. 1A). The mice were bred and genotyped by
polymerase chain reaction (PCR). Genotyping primers were de-
signed as shown in Fig. 1A. Oit3 wild type (WT) mouse were iden-
tiﬁed by the presence of one single DNA product of 333 bp,
whereas heterozygous (+/–) and homozygous (–/–) mice had a
product of 642 bp (Fig. 1B). As shown in Fig. 1C, OIT3 mRNA expres-
sion was absent in liver and kidney of homozygous knockout mice
(–/–) as determined by RT-PCR. The absence of OIT3 protein
expression in the mutant mice was conﬁrmed by Western blotting
(Fig. 1D). Moreover, anti-OIT3 antibody immunohistochemistry
staining also showed that the OIT3 signal was localized in the luminal
membrane of renal tubule in WT mice but not in Oit3 null mice
(Fig. 1E). These results collectively indicated that Oit3 null mice were
successfully established in this study.
3.2. Serum uric acid level is reduced in Oit3 null mice
Within our observation periods, these Oit3 null mice were
viable and fertile without gross abnormalities. We also did not ﬁnd
any abnormal morphological manifestations. To explore the poten-
tial metabolic phenotypes in Oit3 null mice, we assessed the activ-
ity of hepatic enzymes, AST and ALT, as well as the concentration of
Na+, K+, and Cl in the serum of Oit3 null mice. However, we found
no signiﬁcant difference between Oit3 null mice and wild type lit-
termates (Table 1).
Given that OIT3 is expressed in kidney, we next assessed the
putative phenotypes involving kidney functions in Oit3 null mice.
The blood concentrations of creatinine (CRE), and urea nitrogen
(BUN) were measured, and as with the previously mentioned Na+,
K+, and Cl ions, exhibited no signiﬁcant difference between Oit3
null mice and wild type controls (Table 1). However, regardless of
gender, the serum uric acid level was signiﬁcantly reduced in Oit3
null mice as compared to that inWT littermates (P < 0.05) (Table 1).
3.3. Excretion of water and uric acid is increased in Oit3 null mice
To explore the reason for the deceased serum uric acid level in
Oit3 null mice, we ﬁrst evaluated the expression of xanthine
oxidase (XO) and urate oxidase (UOX), which are known to be
responsible for uric acid metabolism in mouse. We did not identify
abnormal expression of these enzymes in Oit3 null mice by RT-PCR
assay (Fig. S1).
Next we checked the uric acid concentration in urine, because
the renal tubule also regulates it via excretion and reabsorption.
Interestingly, a signiﬁcant increase of urine uric acid was found
in female Oit3 null mice (Table 2). Furthermore, total volume of
urine excreted during a 24 h period, including the urine volume
normalized by weight, was also signiﬁcantly increased in femaleFemale
ygous Wild type Homozygous
7.03 35 ± 2.45 34.5 ± 2.08
7.84 15.5 ± 2.08 18.25 ± 3.86
26.52 91 ± 23.15 99.7 ± 13.15
13.07 41.6 ± 20.14 36.85 ± 8.26
0.4 3.11 ± 0.44 3.39 ± 0.63
2.04 148 ± 2.94 144 ± 4.58
0.57 4.56 ± 0.39 4.84 ± 0.34
3.56 105.75 ± 2.5 106 ± 4.58
25.22⁄ 96.0 ± 22.7 71.89 ± 16.43⁄⁄
4.44 12 ± 1.95 13.04 ± 4.63
1.57 10.02 ± 1.87 9.76 ± 3.37
d using ANOVA test. ⁄ and ⁄⁄ indicated P < 0.05 and P < 0.01 for KO mice vs wild type
N, blood urea nitrogen.
Table 2
Urinary indices related to kidney function in wild type and OIT3 null mice.
Items Male Female
Wild type Homozygous Wild type Homozygous
Body weight (g) 23.02 ± 3.28 23.47 ± 1.00 18.6 ± 2.17 19.28 ± 0.66
Volume (ml/day) 0.64 ± 0.34 0.76 ± 0.34 0.515 ± 0.18 0.90 ± 0.43⁄
Volume (ml/g) 0.027 ± 0.015 0.032 ± 0.014 0.028 ± 0.011 0.044 ± 0.022⁄
Na+ (lmmol/day) 186.92 ± 29.91 224.46 ± 112.64 124.7 ± 89.36 155.3 ± 21.9
K+ (lmmol/day) 165.37 ± 34.28 216.28 ± 75.61 147.24 ± 83.68 205.28 ± 25.87
Cl (lmmol/day) 117.91 ± 26.76 140 ± 69.34 81.93 ± 46.8 100.56 ± 13.13
Creatinine (lmol/day) 3.77 ± 0.69 4.53 ± 0.93 3.26 ± 0.91 4.08 ± 0.93
Uric acid (nmol/gday) 16.86 ± 8.52 19.32 ± 9.09 20.71 ± 7.76 32.73 ± 9.07⁄⁄
Osmolality (mosmol/kgH2O) 2325 ± 682.2 2333.3 ± 677.2 2206.7 ± 1284.4 2322.5 ± 767.6
Deprivation of water for 24 h
Volume (ml/day) 0.31 ± 0.18 0.35 ± 0.23 0.25 ± 0.2 0.29 ± 0.11
Osmolality (mosmol/kgH2O) 2688.3 ± 601.9 3240 ± 712.1 2527.5 ± 766.9 3896.7 ± 731.5
Values are means ± S.D.; n = 8–10/genotype and gender. Statistical analysis was performed using ANOVA test. ⁄ and ⁄⁄ indicated P < 0.05 and P < 0.01 for OIT3 null mice vs wild
type mice, respectively.
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concentrations of Na+, K+, and Cl, as well as urine osmolarity,
had no signiﬁcant change. Moreover, we also performed a water
deprivation experiment to assess the water reabsorption of kidney.
After 24 h water deprivation, average urine volume and osmotic
pressure exhibited somewhat of an increase, but this was not
statistically signiﬁcant (Table 2).
3.4. Excretion of renal THP is enhanced in Oit3 null mice
As reported before, uric acid is increased in serum but de-
creased in urine in Thp mutant mice [11]. To address whether
OIT3 functions through THP protein, we ﬁrst assessed the mRNA
level of THP, and found that THP transcription was not obviously
changed in Oit3 null mice (Fig. S2). Signiﬁcantly, the THP protein
level in kidney was decreased in Oit3 null mice, while urine THPFig. 2. THP levels in kidney and urine of OIT3 mull mice. (A) THP and URAT1 levels in ki
compare levels of URAT1 (B) and THP (C) in kidney from wild type and Oit3 null mice.
⁄ indicates P < 0.05, Mann–Whitney U test.was increased, as shown by Western blotting assay (Fig. 2A, C D).
Moreover, we also assessed the expression of URAT1 in Oit3 null
mice. URAT1 functions as a main urate/anion exchanger in the
luminal membrane of the epithelium of renal proximal tubules,
and plays a key role in transporting uric acid into cells from urine
[12]. However URAT1 expression was not signiﬁcantly altered in
Oit3 null mice, as compared to that of WT mice (Fig. 2A and B).4. Discussion
In a quest to reveal the physiological function of OIT3, we
successfully established the Oit3 null mouse model in this study.
Signiﬁcantly, we propose that OIT3 could be involved in renal uric
acid excretion due to the dysregulation of uric acid in serum and
urine in the Oit3 null mice.dney and urine were evaluated by Western blotting assay. Blots were quantiﬁed to
(D) The level of THP in urine from wild type and Oit3 null mice was also analyzed.
764 B. Yan et al. / FEBS Letters 586 (2012) 760–765A similar phenotype was also seen in Thp null mice [8], where
THP has been shown to be a partner of OIT3 in our previous work.
Moreover, mutations in the THP gene were found in familial
juvenile hyperuricaemic nephropathy (FJHN) [13,14], which re-
vealed the central role of THP during uric acid metabolism [15].
Therefore, we suspected the role of OIT3 in renal tubule might
work through the THP protein. Indeed, THP protein was decreased
in kidney but increased in urine from Oit3 null mice. Both OIT3 and
THP belong to the ZP-containing protein family, a protein domain
which might play a role in protein polymerization into ﬁlaments
and/or matrics [16]. THP was observed to form ﬁlaments and could
not be degraded by proteolytic digestion [17]. Herein, we assumed
that OIT3 could bind to THP to form protein polymers, and hence
stabilize THP within renal tubules, thus maintaining the urate
homeostasis. However, as OIT3 was absent in the genetically
engineered mice, the protein polymerization involving both OIT3
and THP would be disrupted, and thereby THP would be excreted
to the urine, which could impair uric acid reabsorption by renal
tubules. It should be pointed out that this hypothesis needs to be
further validated via other animal models, including Oit3 and Thp
double knockout (Oit3/ Thp/) mice.
Multiple ion transporters are localized to the luminal surface of
the thick ascending limb of Henle’s loop [18], including NKCC2,
ROMK,Na+/H+ exchanger (NHE3),KCC4andCIC-Kb [19]. Even though
it was reported before that the THP protein is co-localized with the
NKCC2 [20] and potassium channel ROMK2 in renal outer medulla
[21], we did not see a difference in serum or urinary Na+, K+, and Cl
ions inOit3nullmice.Wepostulate thatNa+, K+, andCl ionsare reab-
sorbed in other fractions of kidney, such as distal tubule and collect-
ing tubule, not overlapping with the OIT3 distribution.
In this study, the enzymes involving uric acid synthesis were not
signiﬁcantly changed in Oit3 null mice, suggesting that OIT3 would
not regulate uric acid level throughmodifyinguric acid synthesis. Here
a signiﬁcant increase of urine uric acid was found only in female Oit3
null mice, which could be associated with androgen action on THP
[22]. However, the molecular mechanisms by which sex hormones,
androgen and estrogen, regulate renal uric acid excretion and reab-
sorptionviaOIT3andTHPareunclear, andneeds tobe further studied.
Nevertheless, our study still indicates a potential role of OIT3 in
some clinical diseases involving uric acid metabolism. In humans, the
main disease associated with uric acid dys-absorption is gout, whose
symptom is hyperuricacidemia [23–25]. The treatment of gout is by
consistently reducing the level of uric acid. Current urate-lowering
drugs use two traditional strategies: inhibition of xanthine oxidase to
reduce production of uric acid [26], using drugs such as allopurinol
and febuxostat [27–29], and promotion of uricosuria to increase its re-
nal excretion,with substances suchasprobenecid andbenzbromarone
[30]. Since the loss of OIT3 reduces uric acid level in serum and en-
hances the excretion of this metabolite, OIT3/LZP could be considered
as a new therapeutic target for hyperuricacidemia.
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